GW-642444 Vilanterol Vilanterol trifenatate
BOC Sciences is committed to supplying cost-effective products and services. We provide Vilanterol trifenatate. Vilanterol, also known as GW-642444, is a long-acting beta-2 agonist drug, which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD). More information please visit: www.bocsci.com/vilanterol-trifenatate-cas-503070-58-4-item-470923.html
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View